Evidence map›Paper›PMID 39433887›Full record

ArticleProstate cancer and prostatic diseases2025

Prostate cancer screening and management in patients candidate for endoscopic enucleation of the prostate: an international survey.

Alessandro Uleri, Jean Nicolas Cornu, Benjamin Pradere, Thomas R W Herrmann, Vincent Misrai, Morgan Roupret, Cosimo De Nunzio, Hashim Hashim, Guillaume Ploussard, Michael Baboudjian

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alessandro UleriDepartment of Urology, APHM, North Academic Hospital, Marseille, France. alessandrouleri@outlook.it.ORCID 0000-0002-2392-2775
Jean Nicolas CornuDepartment of Urology, Charles-Nicolle Hospital, University of Rouen Normandy, Rouen, France.
Benjamin PradereDepartment of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.ORCID 0000-0002-7768-8558
Thomas R W HerrmannDepartment of Urology, Cantonal Hospital Thurgau AG, Fraunfeld, Switzerland.
Vincent MisraiDepartment of Urology, Clinique Pasteur, Toulouse, France.
Morgan RoupretSorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France.
Cosimo De NunzioDepartment of Urology, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-2190-512X
Hashim HashimBristol Urological Institute, Southmead Hospital, Bristol, UK.
Guillaume PloussardDepartment of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.
Michael BaboudjianDepartment of Urology, APHM, North Academic Hospital, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo explore how urologists manage prostate cancer (PCa) screening and treatment in patients undergoing endoscopic enucleation of the prostate (EEP).

methodsA team of experts in EEP collaboratively formulated the survey questions through an interactive process. The survey opened in January 2024 and closed in February 2024.

results102 urologists responded, revealing that most use PSA and digital rectal examination for screening, with high PSA and abnormal DRE prompting prostate MRI. 75% perform pre-EEP biopsies. For incidental low-grade PCa, active surveillance is preferred. For intermediate-grade PCa, most use PSA and MRI for workup, often choosing active surveillance if post-EEP biopsies are negative. There's no consensus on abnormal post-operative PSA thresholds.

conclusionsWhile urologists are aware of PCa management in EEP candidates, future work should focus on developing optimal post-EEP screening protocols.

Indexed as

Early Detection of CancerEndoscopyPractice Patterns, Physicians'Prostatic NeoplasmsDigital Rectal ExaminationDisease ManagementHumansMagnetic Resonance ImagingMaleProstateProstatectomyProstate-Specific AntigenSurveys and QuestionnairesProstate-Specific Antigen

Identifiers

PMID39433887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.